1c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseasesDaniela A.Gutiérrez, América Chandía-Cristi, María JoséYá?ez, Silvana Zanlungo, Alejandra R.álvarez237-2432The mechanism and relevant mediators associated with neuronal apoptosis and potential therapeutic targets in subarachnoid hemorrhageQi Tian, Sheng Liu, Shou-Meng Han, Wei Zhang, Xian-Yao Qin, Jun-Hui Chen, Cheng-Li Liu, Yu-Jia Guo, Ming-Chang Li244-2523Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapyMaría Jose Bellini, Florencia Labombarda253-2574Functions and mechanisms of cytosolic phospholipase A2 in central nervous system traumaHao-Jie Zhang, Yi-Tuo Chen, Xin-Li Hu, Wan-Ta Cai, Xiang-Yang Wang, Wen-Fei Ni, Kai-Liang Zhou258-2665Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?Victoria Sofia Berenice Wies Mancini, Anabella Ayelen Di Pietro, Laura Andrea Pasquini267-2726Cre-recombinase systems for induction of neuron-specific knockout models: a guide for biomedical researchersTetiana Shcholok, Eftekhar Eftekharpour273-2797Prenatal programing of motivated behaviors: can innate immunity prime behavior?Larisa Montalvo-Martínez, Gabriela Cruz-Carrillo, Roger Maldonado-Ruiz, Luis A.Trujillo-Villarreal, Eduardo A.Garza-Villarreal, Alberto Camacho-Morales280-2838Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative reviewFioravante Capone, Mariagrazia Rossi, Alessandro Cruciani, Francesco Motolese, Fabio Pilato, Vincenzo Di Lazzaro284-2889Simulating traumatic brain injury in vitro: developing high throughput models to test biomaterial based therapiesRaja Haseeb Basit, Jessica Wiseman, Farhana Chowdhury, Divya Maitreyi Chari289-29210Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson's diseaseBaptiste Texier, Morgane Prime, Djamaa Atamena, Pascale Belenguer, Marion Szelechowski293-29811The potential of gene therapies for spinal cord injury repair: a systematic review and meta-analysis of pre-clinical studiesCatriona J.Cunningham, Mindaugas Viskontas, Krzysztof Janowicz, Yasmin Sani, Malin E.H?kansson, Anastasia Heidari, Wenlong Huang, Xuenong Bo299-30512The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson's diseaseAnnalucia Serafino, Mauro Cozzolino306-30813Approaches to quantify axonal morphology for the analysis of axonal degenerationAlex Palumbo, Marietta Zille309-31014MicroRNA-based targeting of the Rho/ROCK pathway in therapeutic strategies after spinal cord injuryTetsu Kimura, Yuta Horikoshi311-31215Advances in quantitative analysis of astrocytes using machine learningDemetrio Labate, Cihan Kayasandik313-31416Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic targetMiranda Robbins, Emma L.Clayton315-31617The role of mitochondria in the recovery of neurons after injuryTaylor McElroy, Rola S.Zeidan, Laxmi Rathor, Sung Min Han, Rui Xiao317-31818Turning up the NAD+-mitophagy axis to treat Alzheimer 's diseaseEvandro F.Fang, Alexander Anisimov31919Kainate receptors in the CA2 region of the hippocampusYuniesky Andrade-Talavera, Antonio Rodríguez-Moreno320-32120Understanding the timing of brain injury in fetal growth restriction: lessons from a model of spontaneous growth restriction in pigletsHannah Musco, Julie A.Wixey322-323 